• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病与多发性硬化症的共病——一则重要提示。

Co-occurrence of parkinson disease and multiple sclerosis - a critical note.

作者信息

Jellinger Kurt A

机构信息

Institute of Clinical Neurobiology, Alberichgasse 5/13, Vienna, A-1150, Austria.

出版信息

J Neural Transm (Vienna). 2025 Apr 11. doi: 10.1007/s00702-025-02922-2.

DOI:10.1007/s00702-025-02922-2
PMID:40214766
Abstract

While multiple sclerosis (MS) is associated with various movement disorders, in particular tremor and ataxia, its combination with parkinsonism is rare and co-occurrence of MS and Parkinson disease (PD) has been reported in only few definite cases. Theories about this co-occurrence range from coincidental to causal, but the true prevalence, basic features and causal relations between the two entities have not been systemically evaluated. Although there are cases of causal relationship between parkinsonism and MS related to demyelinating lesions affecting the dopaminergic nigrostriatal pathway, in a limited number of cases, PD (some gene-mediated) and MS may coexist as two separate diseases in the same patients. The prevalence of MS in LRRK2 PD, while rare, supports an important role for immune function in both disorders, while the role of PD-related PINK is still open. Furthermore, several common genes such as BACE2, CD69, CLC, CPA3 and DEFAs may play important roles in MS and PD, while MS and PD share iron accumulation in substantia nigra, which may be due to protein-protein interaction networks related to metal homeostasis. In view of the various pathogenic possibilities, the causal relationship of concurring MS and PD deserves critical consideration.

摘要

虽然多发性硬化症(MS)与各种运动障碍有关,尤其是震颤和共济失调,但其与帕金森综合征的合并情况较为罕见,仅在少数明确病例中报道过MS与帕金森病(PD)同时出现。关于这种同时出现的理论从巧合到因果关系都有,但这两种疾病之间的真实患病率、基本特征和因果关系尚未得到系统评估。虽然存在与影响多巴胺能黑质纹状体通路的脱髓鞘病变相关的帕金森综合征与MS之间存在因果关系的病例,但在少数情况下,PD(一些由基因介导)和MS可能作为两种独立的疾病共存于同一患者体内。LRRK2相关帕金森病中MS的患病率虽然很低,但支持免疫功能在这两种疾病中都发挥重要作用,而与PD相关的PINK的作用仍不明确。此外,一些常见基因如BACE2、CD69、CLC、CPA3和防御素(DEFAs)可能在MS和PD中发挥重要作用,而MS和PD在黑质中都存在铁蓄积,这可能归因于与金属稳态相关的蛋白质-蛋白质相互作用网络。鉴于各种致病可能性,MS和PD同时出现的因果关系值得深入探讨。

相似文献

1
Co-occurrence of parkinson disease and multiple sclerosis - a critical note.帕金森病与多发性硬化症的共病——一则重要提示。
J Neural Transm (Vienna). 2025 Apr 11. doi: 10.1007/s00702-025-02922-2.
2
Multiple sclerosis in G2019S Parkinson's disease and isolated nigral degeneration in a homozygous variant carrier.G2019S帕金森病中的多发性硬化症以及纯合变异携带者中的孤立性黑质变性。
Front Neurol. 2024 Aug 8;15:1450654. doi: 10.3389/fneur.2024.1450654. eCollection 2024.
3
Parkinsonism in multiple sclerosis patients: A prospective observational study.多发性硬化症患者的帕金森病:一项前瞻性观察研究。
Mult Scler Relat Disord. 2022 Jun;62:103796. doi: 10.1016/j.msard.2022.103796. Epub 2022 Apr 10.
4
Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis.帕金森病或多发性硬化症患者黑质中的金属动态失衡。
J Neurochem. 2024 Feb;168(2):128-141. doi: 10.1111/jnc.16040. Epub 2024 Jan 5.
5
Parkinsonism and multiple sclerosis--is there association?帕金森症与多发性硬化症——它们有关联吗?
Clin Neurol Neurosurg. 2008 Nov;110(9):958-61. doi: 10.1016/j.clineuro.2008.03.019. Epub 2008 May 15.
6
Chapter 33: the history of movement disorders.第33章:运动障碍病史。
Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7.
7
Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.帕金森病、进行性核上性麻痹和帕金森综合征型额颞叶痴呆中黑质的表达谱分析。
Arch Neurol. 2005 Jun;62(6):917-21. doi: 10.1001/archneur.62.6.917.
8
Homozygous mutation of the LRRK2 ROC domain as a novel genetic model of parkinsonism.LRRK2 ROC 结构域纯合突变:一种新型帕金森病遗传学模型。
J Biomed Sci. 2022 Aug 14;29(1):60. doi: 10.1186/s12929-022-00844-9.
9
Multiple sclerosis and risk of Parkinson's disease: a Danish nationwide cohort study.多发性硬化症与帕金森病风险:一项丹麦全国队列研究。
Eur J Neurol. 2014;21(1):107-11. doi: 10.1111/ene.12255. Epub 2013 Sep 19.
10
α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.α-突触核蛋白、富亮氨酸重复激酶 2 和锰在帕金森病发病机制中的作用。
Neurotoxicology. 2011 Oct;32(5):622-9. doi: 10.1016/j.neuro.2011.01.003. Epub 2011 Jan 14.

本文引用的文献

1
Epidemiology of Multiple Sclerosis: Global, Regional, National and Sub-National-Level Estimates and Future Projections.多发性硬化症的流行病学:全球、区域、国家和次国家层面的估计及未来预测。
J Epidemiol Glob Health. 2025 Feb 10;15(1):21. doi: 10.1007/s44197-025-00353-6.
2
Global, regional, national epidemiology and trends of Parkinson's disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021.1990年至2021年帕金森病的全球、区域、国家流行病学及趋势:全球疾病负担研究2021的结果
Front Aging Neurosci. 2025 Jan 10;16:1498756. doi: 10.3389/fnagi.2024.1498756. eCollection 2024.
3
Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis.
迈向多发性硬化症统一诊断标准集
Ann Neurol. 2025 Mar;97(3):571-582. doi: 10.1002/ana.27145. Epub 2024 Nov 28.
4
Multiple sclerosis in G2019S Parkinson's disease and isolated nigral degeneration in a homozygous variant carrier.G2019S帕金森病中的多发性硬化症以及纯合变异携带者中的孤立性黑质变性。
Front Neurol. 2024 Aug 8;15:1450654. doi: 10.3389/fneur.2024.1450654. eCollection 2024.
5
Temporal trends in the prevalence of Parkinson's disease from 1980 to 2023: a systematic review and meta-analysis.1980 年至 2023 年帕金森病患病率的时间趋势:系统评价和荟萃分析。
Lancet Healthy Longev. 2024 Jul;5(7):e464-e479. doi: 10.1016/S2666-7568(24)00094-1.
6
Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions.通过识别独立的神经病理学维度来解开多发性硬化症的异质性。
Acta Neuropathol. 2024 May 21;147(1):90. doi: 10.1007/s00401-024-02742-w.
7
Update: Descriptive epidemiology of Parkinson disease.更新:帕金森病的描述性流行病学。
Parkinsonism Relat Disord. 2024 Mar;120:106000. doi: 10.1016/j.parkreldis.2024.106000. Epub 2024 Jan 8.
8
Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis.帕金森病或多发性硬化症患者黑质中的金属动态失衡。
J Neurochem. 2024 Feb;168(2):128-141. doi: 10.1111/jnc.16040. Epub 2024 Jan 5.
9
Parkinson' s disease complicated after 12 years from the onset of multiple sclerosis.帕金森病在多发性硬化症发病12年后出现并发症。
Neurol Sci. 2024 Apr;45(4):1775-1778. doi: 10.1007/s10072-023-07201-0. Epub 2023 Nov 16.
10
Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer's disease, Parkinson's disease, and multiple sclerosis.整合单细胞序列分析揭示阿尔茨海默病、帕金森病和多发性硬化症的转录动态。
J Transl Med. 2023 Sep 21;21(1):649. doi: 10.1186/s12967-023-04516-6.